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Pediatric cardiovascular services are responding to the dynamic changes in the medical environ-
ment, including the business of medicine. The opportunity to advance our pediatric cardiology field
through collaboration is now realized, permitting us to define meaningful quality metrics and estab-
lish national benchmarks through multicenter efforts. In March 2016, the American College of
Cardiology hosted the first Adult Congenital/Pediatric Cardiology Section Congenital Heart Com-
munity Day. This was an open participation meeting for clinicians, administrators, patients/parents
to propose metrics that optimize patient care and outcomes for a state-of-the-art congenital heart
center of the 21st century. Care center collaboration helps overcome the barrier of relative small
volumes at any given program. Patients and families have become active collaborative partners
with care centers in the definition of acute and longitudinal outcomes and our quality metrics.
Understanding programmatic metrics that create an environment to provide outstanding congeni-
tal heart care will allow centers to improve their structure, processes and ultimately outcomes,
leading to an increasing number of centers that provide excellent care. This manuscript provides
background, as well listing of proposed specialty domain quality metrics for centers, and thus
serves as an updated baseline for the ongoing dynamic process of optimizing care and realizing
patient value.
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1 | INTRODUCTION
Care for children and adults with pediatric and congenital heart disease
illustrate the power and possibility of modern medicine. Continuous
advancement of therapies and services available to serve patients and
families has rendered previously untreatable illnesses manageable, with
many individuals affected by these conditions now living into adult-
hood and functioning well in society. Coupled with these successes,
and perhaps contributing to them, has been a rising focus by hospitals
and providers on measuring patient outcomes and experience and
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enhancing transparency regarding quality of care in communication
with patients and families.
In 2002, the American Academy of Pediatrics published “Guide-
lines for Pediatric Cardiovascular Centers.”1 The objective of this state-
ment was to describe critical elements of a pediatric cardiovascular
center necessary for achieving the best patient outcomes. When this
statement was written multicenter measurement and quality improve-
ment efforts were in their early infancy. Over the past fifteen years
there have been advances in our understanding of cardiac physiology,
diagnostic tools and therapeutic techniques. Our understanding of
important components of care associated with excellent patient out-
comes has also improved.
In addition to medical and surgical advances, several other factors
impact the structure and practice of congenital heart disease care. First,
the volume and variety of data captured at care centers and across
data registries has expanded exponentially.2 Second, there has been a
heightened focus on transparency and reporting of data. This move-
ment has been led by providers inspired by patients/families collaborat-
ing to improve practice and outcomes, patients and families seeking
information to help make decisions about where to receive care, and
payers interested in seeking centers with best outcomes and lowest
costs.3–5 The availability of vast outcome data allowed several external
organizations to provide the public with information about hospital per-
formance and even to create rankings of programs. The most promi-
nent examples of public reporting in our field include US News and
World Report and the Society of Thoracic Surgeons (STS). While
patients and families have fought for access to clinical outcomes data,
they have also advocated for systems of care and specific processes
that are more patient- and family-centered, promoting shared decision-
making principles integral to their child’s care.6 Finally, clinicians and
researchers shifted their focus to quality metrics beyond mortality and
morbidity as important factors in defining high-value care. The Institute
of Medicine provided one framework for considering outcomes and
value holistically and outlined six domains of quality in healthcare: safe,
effective, patient-centered, timely, efficient, and equitable.7 There is
now an increased focus on understanding patient and family experi-
ence as a metric of value in care delivered.
The aim of this project was to describe the structure, function, and
critical outcome measures that would allow the congenital heart center
of the 21st century to achieve the best value for patients with congeni-
tal heart disease. Uniquely, this particular project was imagined and
executed by providers, rather than centers or external organizations,
and has been inspired and guided by the voice of parents and patients,
each group demanding a better understanding of what drives great
short and long-term clinical outcomes.
2 | METHODS
The topic of programmatic metrics in congenital heart disease centers
was the subject of the first Congenital Heart Community Day, held in
conjunction with the 2016 American College of Cardiology Annual
Meeting. This full day was attended by a broad representative group of
cardiologists, surgeons, nurses, parents and administrators. Through ple-
nary talks and breakout sessions, groups from multiple domains within
the larger cardiac care community began to propose metrics that define
great congenital heart programs using several foundational principles.
These topics were further discussed and refined at the Twelfth Annual
Meeting of The Multi-Societal Database Committee for Pediatric and
Congenital Heart Disease (Wednesday, August 24, 2016 and Thursday,
August 25, 2016 at the Emory Conference Center, Atlanta, Georgia).
In defining appropriate programmatic metrics we used several foun-
dational principles. Donabedian, a physician and health services
researcher, developed a conceptual model that frames health services
and quality of care around three categories: structure, process and out-
comes. Structure describes the context in which care is delivered, and
includes physical structures, supplies and equipment. Process is the flow
and interaction of patients through the care delivery system and the
interaction with care givers. Finally, outcomes refer to the health status
of the patient receiving care in the system.8 Porter further delineated
the complexity of health outcomes in his model of value in healthcare.
Outcomes, according to Porter, include short-term outcomes, such as
mortality, but also must include long-term functional outcomes as well.9
We followed the frameworks outlined by Donabedian and Porter
and organized our discussion of metrics around process, structure and
outcome.8,9 The first draft of these metrics was created by workgroups
during the Congenital Heart Community Day. For each cardiology
domain (Table 1) project leaders defined programmatic metrics for their
domain based on best available data, evidence and content expertise.
Finally, each group defined gaps that currently exist in our knowledge
about programmatic quality and outcomes, to act as a guide for future
research on more refined metrics. What follows is a description and list
of proposed programmatic metrics from each domain.
2.1 | Administration
The congenital heart center Administration domain requires close align-
ment with clinical care. Physician and administrative leadership opti-
mally function through a dyad relationship, to ensure that all aspects of
the congenital heart center meet the needs of patients and families.
Physician leadership input regarding strategic direction, financial
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decisions, programs, and clinician performance metrics is vital. Commu-
nication with all members of the program ensures alignment with mis-
sion and heightens engagement of staff. Structure and process are
cornerstones of the Administration domain, to ensure that comprehen-
sive clinical facilities, equipment, skilled personnel, and pertinent
resources are available. Patients with complex congenital heart defects
require advanced clinical services and therapies/treatments, advanced
technology (eg, ECMO, mechanical ventricular assist device), clinical
support services, and seamless transition or continuation to adult con-
genital heart care. Comprehensive specialty programs, (arrhythmia, pul-
monary hypertension, aorta and vascular, neurodevelopmental care,
etc) and services support need to be readily available. A comprehensive
outpatient network allows local care to be delivered locally in the com-
munities, also ensuring efficient and effective communication with the
inpatient center through the use of electronic medical records.
Advanced health information technology is now the standard and
becomes a cornerstone for accountable care organizations or clinically
integrated networks. Timely access to care (perhaps best quantitatively
measured as cancellation rate for surgical procedures or time to third
next available appointment in the outpatient arena) has become an
important outcome measure for busy and at-capacity heart centers.
Centralized cardiac patient scheduling and concierge services assist
with coordination of care and patient experience.
The Administration domain is also responsible for the documenta-
tion of quality for providers and the heart program. Certification of pro-
grammatic structures and processes and the credentialing of clinical
care providers and staff, including maintenance of certification, becomes
the responsibility for the congenital heart center. Children’s hospitals
and pediatric cardiac programs are now ranked through an annual US
News and World Report survey. Centers are externally accredited
through Joint Commission, Magnet, or Beacon recognition, and other
subspecialty accreditation programs. Centers should participate in key
national clinical registries and patient care and safety collaboratives for
benchmarking and adoption of best practices, generation of center-
specific registry-documented results, and transparency through public
reporting. Engagement of the patient and family is essential in improv-
ing operations and their experience. Use of a survey instrument such as
HCAHPS (Hospital Consumer Assessment of Healthcare Providers and
Systems) measures patients’ perceptions of their hospital experience.10
The HCAHPS survey is an example of an experience survey that pro-
vides a national standard for collecting and publicly reporting informa-
tion about patient experience. The engagement of families who actively
participate in a formal advisory role will assist the center in improving
the day-to-day operations and patient/family experience.
For the business of medicine, it is expected that centers will
begin transitioning from volume-based care (fee for service) to a
value-based reimbursement structure (fee for value) with evolving
contract and reimbursement strategies. Fee for value payment mod-
els prompt a center to deliver the best care at the lowest cost. As
centers aim to respond to the changing market forces, they may
consider involvement with clinically integrated networks for demon-
strating patient care coordination. Participation with group purchas-
ing organizations may allow for competitive pricing on supply/
equipment resources.11 Physician-developed clinical pathways can
reduce error and eliminate unnecessary variability which may
improve quality of care and reduce costs. Implementing team-based
models utilizing advance practice providers (APPs) to extend physi-
cians and to manage clinical programs may allow for more effective
and efficient far reaching care delivery. Suggested administrative
metrics can be found in Table 2.
TABLE 2 Administration metrics
Metric Domain Definition
1. Structure Core certifications for Physicians, APPs, and Nurses (Board Certification, APP Certification, CCNC)
2. Structure Nurse to Patient Ratio
3. Structure Core Accreditation/Credentialing/Recognition: Joint Commission, Beacon, Magnet, Sub-Specialty Accreditation Programs
4. Structure Dedicated Services/Programs/Facilities: Dedicated Cardiac ORs; Dedicated Cardiac Anesthesia Services; Inpatient
Cardiology Consultation; Cardiac Intensive Care Unit; Remote monitoring of Cardiac patients (telemetry); Noninva-
sive cardiac imaging, CT and MRI; Cardiac Interventional Cath Lab/Diagnostic Cath Lab/EP Lab; Adult Congenital
Heart Program; ECMO; Heart Transplant and Heart Failure Program; Mechanical Device Program; Cardiac Genetics
Clinic; Cardiac Neurodevelopmental Care Program; Pediatric Cardiac Anesthesia services; Diagnostic modalities
(Echo, CT, cMRI); Cardiopulmonary Exercise testing; Telemedicine; Specialty Programs (Fetal Cardiology, Aortopathy,
Arrhythmia, Pulmonary Hypertension, Preventive Cardiology, etc).
Consultative services to manage noncardiac issues in the cardiac patient (neurology, nephrology, GI, infectious disease,
nutrition, social work, pharmacy, transfusion services, etc).
5. Structure Participation in Core Clinical Registries/Collaboratives: STS Congenital Cardiac Surgery; STS Congenital Cardiac
Anesthesia Society; NCDR-IMPACT; C3PO-QI; PC4 or VPS; PAC3; National Pediatric Cardiology Quality Improvement
Collaborative (NPC-QIC); Solutions for Patient Safety Collaborative (SPS); ELSO
6. Structure Engaged Cardiac Patient/Family Advisory Group
7. Process Transparency of Surgical Outcomes
8. Process Transparency of Patient Experience
9. Process Surgery cancellation rate (not related to patient illness or cause)
10. Process Standardized physician communication for inpatient care and discharge, postdischarge follow-up care
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2.2 | Adult congenital
The care of adults with congenital heart disease and the subspecialty
cardiovascular field of adult congenital heart disease (ACHD) have rap-
idly developed over the past several decades and in parallel the recog-
nition and importance of ACHD quality metrics (QM). The ACHD
domain benefited from ACHD patient and family collaboration, leading
the way to shared decision making and definition of meaningful quality
metrics. The 2008 ACC/AHA guidelines for the management of adults
with congenital heart disease set the stage for future ACHD quality
measures and metrics.12 By providing for the first time weighted,
evidence-based guidelines, structured in a lesion-specific format, the
blueprint was in place for lesion-specific quality metrics. Developed
over a several-year process, 55 quality indicators were proposed for 6
ACHD conditions in 2013.13 The process to derive the first set of
ACHD quality indicators was based on utilizing an expert panel review-
ing previously published ACHD guidelines and proposing indicators
that met standards for validity and feasibility, eventually paring down
to the final set of measures. During this same time, the ACC through
the ACPC council developed the Quality Metric Working Group to pro-
pose CHD QMs. The ACHD working group in cooperation with the
quality metric working group developed the first CHD QM—Complete
Aortic Evaluation for Adults with Repaired Coarctation of the Aorta.
The 24 QMs listed through the ACPC section can be found on the
ACPC Quality Network website.14
Although the field of ACHD had made great strides through the
2008 ACC/AHA ACHD Care Guidelines and the 2013 ACHD lesion
specific quality indicators, there still was great need to develop more
structured QMs. As early as 2001, with the 32nd Bethesda Conference
on the Care of the Adult with Congenital Heart Disease, experts had pro-
posed the development of ACHD care centers and specific ACHD
training for cardiologists interested in caring for this population.15
ACHD care centers/programs would create a care model that included
not only the ACHD cardiologist, but advanced practice practitioners,
and subspecialists in related fields that care for the ACHD patient; for
example, interventional cardiology, electrophysiology, cardiothoracic
surgery, echocardiography, intensive care. To this point only proposed
as an important QM, Marelli and colleagues demonstrated as an out-
come QM that patients referred to specialized ACHD programs in Can-
ada experienced a significant reduction in mortality.16 In 2012, the
Adult Congenital Heart Association (ACHA) took on the challenge to
develop accredited ACHD Care Centers meeting criteria standards
through a detailed application and a site visit. The ACHA Program
Accreditation process embeds QM throughout the proposed standards
and criteria that must be met to become accredited.17 There are 19
sections and over 100 individual ACHD care criteria. The accredited
care centers will develop quality initiatives through the QM sharing
among the centers.
To meet the needs of the ACHD patients and the standards of an
ACHD care center, in 2007 a proposal was submitted to the American
Board of Internal Medicine and simultaneously to the American Board
of Pediatrics to create a subspecialty board certification for ACHD. In
2012, ACHD subspecialty certification was approved by the American
Board of Medical Specialties and in October 2015, the first ACHD cer-
tifying board examination was administered. Accreditation Council for
Graduate Medical Education (ACGME) approval for ACHD training fol-
lowed board certification, and a 2-year curriculum was approved to be
completed after either internal medicine or pediatric cardiology train-
ing. Both ABIM/ABP ACHD board certification and ACGME ACHD
training programs are structured QMs meeting the highest standards
for training and certifying physicians in the US.
Both process and structure QMs have been developed in ACHD
to improve the care of ACHD patients and form a basis for quality
improvement. We now have ABM/ABP board certified cardiologists
incorporated into an ACHA-accredited program collecting QM data
and developing multispecialty quality initiatives. The field is primed for
improved access and quality of care delivered to this underserved pop-
ulation. Suggested Adult congenital metrics can be found in Table 3.
2.3 | Ambulatory
Measurement of quality care in ambulatory pediatric cardiology has
lagged behind other domains of the service line, for example, cardiac
intensive care unit, interventional catheterization laboratory, and car-
diac surgery. While many pediatric outpatients are followed for com-
plex cardiac diagnoses after multiple interventional and surgical
procedures, another large volume of patients is evaluated for what ulti-
mately proves to be noncardiac signs and symptoms. In the adult cardi-
ology sphere, the NCDR PINNACLE registry is the largest
observational outpatient cardiac registry in the world, for patients with
coronary disease, hypertension, heart failure, or atrial fibrillation.18 Sim-
ilar evidence-based physician performance metrics do not yet exist for
pediatric cardiology. Only recently, the ACC has undertaken a process
to develop quality metrics in 5 areas of interest—chest pain, postopera-
tive tetralogy of Fallot, postoperative arterial switch repair for transpo-
sition of the great arteries, Kawasaki disease, and infectious disease
issues (flu vaccine, SBE prophylaxis, Synagis, rheumatic fever). A
description of the development of these metrics has been published.19
These metrics are currently being operationalized through the ACC
ACPC Quality Network (QNet).20 Most of these metrics are process
measures; efforts to develop patient outcome measures should be
supported.
The development of, and endorsement of, multicenter clinical
care pathways may help guide outpatient diagnosis and treatment and
eliminate unnecessary variability. Appropriate use criteria for
TABLE 3 Adult congenital metrics
Metric Domain Definition
1. Structure ACHD lesion-specific quality indicators as pub-
lished13
2. Structure Physicians caring for ACHD patients are ACHD
ABIM/ABP Board Certified
3. Structure Program is ACHD Accredited
4. Structure ACHD cardiologists complete an AGME ap-
proved fellowship training program
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echocardiography during the initial evaluation of patients represent a
first step to direct imaging based on vetted criteria.21 The National Pedi-
atric Cardiac Quality Improvement Collaborative (NPCQIC) has proven
highly successful to advance best practice care for the management of
interstage patients with hypoplastic left heart syndrome.22 This multi-
center collaboration amongst physicians, other cardiac care team staff,
and families has generated protocols and check lists that are optimizing
patient outcome.
Another methodology that has demonstrated improvement in
approaches to outpatient management has been the Standardized Clin-
ical Assessment and Management Plans (SCAMPs) program.23 SCAMPs
act as clinical guidelines but permit knowledge and experience-based
diversions from suggested guidelines. This approach has been applied
to diverse pediatric cardiology conditions such as pediatric chest pain,
syncope, balloon dilation for congenital aortic stenosis, and the postop-
erative management of the arterial switch operation, demonstrating
reductions in resource utilization while maintaining quality of care.24–27
This standardized approach to cardiac care, along with methods such
as appropriate use criteria, improve care while minimizing overutiliza-
tion of resources.
Access to care, and cost of delivering these services, is becoming a
focal point for cardiac service lines. Time to third next available
appointment has been proposed as a standard process measure but
may not be applicable to specialty programs such as pulmonary hyper-
tension, aortopathy, and so forth. that meet infrequently. Provision of
comprehensive noninvasive diagnostic services in outpatient offices is
an expensive proposition, which may be offset through the alternative
care delivery model of telemedicine and/or the development of team-
based care, with advanced practice providers supplanting physicians.
One of the major changes in delivery of ambulatory care is the
development of integrated practice units (IPUs) which engage multidis-
ciplinary specialists and nonclinical staff to provide comprehensive care
of complex patients. Examples include single ventricle survivorship pro-
grams and neurodevelopmental assessment programs, now present in
many large US congenital heart disease programs. Similarly, arrhythmia
services and sudden cardiac arrest programs, heart failure programs,
pulmonary artery hypertension and aortopathy programs are now
being developed at many centers to provide care for these complex
patient subsets.
The field of ambulatory pediatric cardiology provides a ripe target
for the development of objective structure, process, and patient out-
come metrics. Collaboration among programs, which can be advanced
through the ACC ACPC Section, should be furthered. Suggested Adult
congenital metrics can be found in Table 4.
2.4 | Cardiac critical care
Cardiac critical care represents a key discipline necessary to achieve
excellent outcomes at successful congenital heart centers. It is impera-
tive to develop a clear understanding of the critical care team’s impact
on patient outcomes and the quality of care provided in cardiac inten-
sive care units (CICU). Multiple databases now exist to measure and
understand variation in practice and outcomes. Two primarily North
American databases—the Virtual PICU System (VPS, LLC, Los Angeles)
and the Pediatric Cardiac Critical Care Consortium (PC4) clinical
registry—focus solely on critically-ill patients, while many others include
some data related to critical care (eg, surgical databases). Of these, the
PC4 clinical registry is the only database exclusively dedicated to
the cardiac critical care population.
Outcome measures used for pediatric cardiac critical care quality
assessment should reflect the competence and performance of the
CICU team, and be independent of care provided and outcomes real-
ized prior and subsequent to the CICU admission. Ideal metrics of
CICU quality would be outcome measures (as opposed to structure or
process measures) and appropriately risk-adjusted to account for
patient factors. Existing risk-adjustment models used in cardiac surgical
and general pediatric critical care outcomes assessment are insufficient
for measuring CICU performance, particularly when considering quality
of postoperative care. Further, most existing methods focus on mortal-
ity as the clinical endpoint, and several nonmortality metrics such as
complications, functional status at discharge, and resource utilization
may be important markers of quality in the CICU. A number of properly
adjusted metrics will be available in the near future. When considering
structure and process measures, evidence to support an association
between these measures and outcomes in CICU patient populations is
weak at best.
Further complicating the approach to outcomes assessment and
defining quality in the CICU is the heterogeneity of hospital inpatient
service structure and the interdependence of CICU and non-ICU/ward
resources. Potential metrics such as CICU readmissions and CICU
length of stay can be difficult to measure and/or hard to interpret
across hospitals due to these system differences. Proposed metrics
should account for these differences and reflect the quality of CICU
care and decision making independent of what structures and resour-
ces exist in non-CICU wards. Further efforts to integrate quality assess-
ment with clinicians and researchers focusing on non-ICU inpatient
TABLE 4 Ambulatory metrics
Metric Domain Definition
1. Structure Participation in quality improvement programs:
NPCQIC, ACC QNet
2. Structure Availability of comprehensive noninvasive ima-
ging, on-site or through telemedicine
3. Structure Availability of IPU programs and cardiac sub-
specialists, including electrophysiology, heart
failure, preventive cardiology, adult congenital,
cardiovascular genetics, cardiac neurodeve-
lopmental follow up, fetal cardiology, pulmon-
ary hypertension
4. Process ACC approved ambulatory quality metrics19
5. Process Utilization of standardized clinical guidelines for
outpatient management
6. Process Measurement of patient access to outpatient
clinics
7. Process Timely structured communication to referring
physicians
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care will be imperative to best inform congenital heart centers on out-
comes and performance. Suggested Cardiac Critical Care metrics can
be found in Table 5.
2.5 | Cardiothoracic surgery
The Society of Thoracic Surgeons (STS) and the Congenital Heart Sur-
geons’ Society (CHSS) have endorsed 21 metrics to assess the quality of
care delivered to patients with pediatric and congenital cardiac disease
undergoing cardiac surgery.28 Published in 2012, these 21 “Quality
Measures for Congenital and Pediatric Cardiac Surgery” were developed
by STS and are organized according to Donabedian’s Triad of Structure,
Process, and Outcome, with 5 structure measures, 6 process measures,
and 7 outcome measures.8 Of these 21 quality measures published by
STS and CHSS, three have been endorsed by the National Quality
Forum. In addition, the National Quality Forum has endorsed a fourth
quality measure developed by STS: Risk-adjusted operative mortality.
Risk-adjusted operative mortality for pediatric and congenital heart
surgery is reported using the 2014 STS Congenital Heart Surgery Data-
base (CHSD) Mortality Risk Model, which facilitates description of
Operative Mortality adjusted both for procedural factors and for
patient level factors.29–32 This model, which includes procedural factors
as well as individual patient factors, is the most comprehensive and
most sophisticated risk model for congenital and pediatric heart surgery
in use at the present time.32 Assessment of model fit and discrimina-
tion in the development sample and the validation sample revealed
overall C statistics of 0.875 and 0.858, respectively. Coefficients for
variables in the model are re-estimated every six months to ensure that
the model remains well calibrated for its use as a platform for bench-
marking programmatic outcomes to national aggregate data and also
for public reporting of pediatric and congenital cardiac surgical pro-
grammatic outcomes. In the future, when models have been developed
that encompass other outcomes in addition to mortality, it will be
possible to assess pediatric and congenital cardiac surgical performance
using a multidomain composite metric that incorporates both mortality
and morbidity, adjusting for the operation performed and for patient-
specific factors.29 It is expected that, in the future, the entirety of this
information will also be publicly reported.
Because over 95% of programs performing pediatric cardiac sur-
gery submit data to the STS CHSD, the current national aggregate con-
genital and pediatric cardiac surgical outcomes contained in STS CHSD
can serve as a platform for benchmarking performance and improving
quality. These activities of outcomes analysis and quality improvement
will ultimately allow congenital heart centers to provide better care for
patients. Suggested Cardiothoracic surgery metrics can be found in
Table 6. The full set of 21 “Quality Measures for Congenital and Pediat-
ric Cardiac Surgery” developed by STS have been previously published.8
2.6 | Electrophysiology
Arrhythmia management, particularly cardiac ablation procedures and
cardiac implantable electronic devices (CIEDs) — implantable cardiac
TABLE 5 Cardiac critical care metrics
Metric Domain Definition
1. Outcome Adjusted CICU postoperative mortality (standardized mortality ratio or adjusted rate) calculated using either (a)
PC4 surgical mortality model or (b) VPS PICSIM model
2. Outcome Adjusted CICU medical mortality (standardized mortality ratio or adjusted rate) calculated using either (a) PC4
medical mortality model or (b) PRISM-III
3. Outcome Risk-adjusted rate of unplanned CICU readmissions within 48 hours of transfer or discharge
4. Outcome Risk-adjusted postoperative CICU length of stay
5. Outcome Risk-adjusted extubation failure rate (% reintubation within 48 hours after planned extubation)
6. Outcome Risk-adjusted cardiac arrest incidence rate
6. Outcome Device-associated infection rates (CLABSI, CAUTI)
8. Structure Participation in a multi-institutional ICU clinical registry and/or quality improvement collaborative
9. Structure Program to provide ECLS
10. Structure Aggregate nursing education/experience and staffing (hours per patient day)
11. Process Resuscitation debriefing program
12. Process Structured OR to ICU handoff following surgical procedures
TABLE 6 Cardiothoracic surgery metrics
Metric Domain Definition (*5NQF endorsed)
1. Outcome *Risk-adjusted operative mortality
2 Outcome *Operative Mortality Stratified by the Five STS-
EACTS Mortality Levels
3. Structure *Participation in a National Database for Pediatric
and Congenital Heart Surgery
4. Structure *Surgical volume for Pediatric and Congenital Heart
Surgery: Total Programmatic Volume and Pro-
grammatic Volume Stratified by the Five STS-
EACTS Mortality Categories
The full set of 21 “Quality Measures for Congenital and Pediatric Cardiac
Surgery” developed by STS have been previously published.8
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defibrillators, pacemakers, cardiac resynchronization therapies — lends
itself toward quality metric and outcomes measurement. Data for qual-
ity metric and outcome measurement in pediatric electrophysiology
was first considered by the Pediatric Electrophysiology Society, which
began informally meeting in the early 1980s to discuss pediatric
patients with arrhythmias. The name subsequently changed to the
Pediatric and Congenital Electrophysiology Society (PACES) to reflect
the inclusion of the growing adult congenital population, with addi-
tional providers and centers. The Pediatric Radiofrequency Catheter
Ablation Registry (1991–1999), a voluntary procedural registry, eval-
uated early procedural successes and failures, procedure and fluoros-
copy times, arrhythmia recurrence following initially successful
procedures, and demonstrated the concept of a procedural learning
curve.33 Prospective Assessment after Pediatric Cardiac Ablation
(PAPCA) was a 1999–2003 prospective study and clinical registry.34
PAPCA further defined successes, complications, and recurrences of
procedures stratified by the underlying electrophysiological substrate,
documented a modest decrease in average fluoroscopy times com-
pared to the initial ablation registry, and identified no substantive evi-
dence for inadvertent injury to cardiac valves or coronary arteries as a
result of a radiofrequency ablation procedure. These registries have
come and gone, now replaced with the Multicenter Pediatric and Adult
Congenital EP Quality (MAP-IT) registry, affiliated with the IMPACT
registry through the NCDR. MAP-IT has the promise and potential to
define current era outcomes in the presence of new ablation technolo-
gies (eg, cryoablation), the use of advanced imaging and diagnostic
modalities (eg, fluoroless imaging), and an increasing ACHD patient
population.35,36 This registry should provide the infrastructure for qual-
ity assurance and multicenter research. All 3 registries have provided
individual center and provider performance relative to national per-
formance benchmarks. The adoption of standardized quality of life sur-
veys for subjective assessment of arrhythmia relief and the
development of longitudinal long-term outcomes should be pursued.
CIEDs represent expensive and effective treatment options for
many patients, and thus warrant outcome measurement and reporting.
Published guidelines exist for appropriate implantation of these
devices.37 Outcome measures can and should include indication for
implantation, underlying substrate (electrophysiologic substrate and/or
the presence of structural heart defects), procedural approach (epicardial,
transvenous, subcutaneous), as well as acute and long-term outcomes
including successes and complications. Pediatric and ACHD patients can
be tracked through the currently available NCDR ICD registry.
In addition to outcome metrics, pediatric electrophysiology has
learned from other procedural fields to incorporate safety process meas-
ures to their procedures, especially in the areas of procedural communica-
tion and utilizing checklists. Finally, as with other specialties, it is felt that
participation in data sharing and learning from others through national
registries is an important marker of quality in pediatric electrophysiology.
Suggested Electrophysiology metrics can be found in Table 7.
2.7 | Inpatient care
Hospital-based cardiac care outside of the intensive care unit is an
emerging field of interest and investment within pediatric cardiology.
TABLE 7 Electrophysiology metrics
Metric Domain Definition
1. Outcome Proportion of manifest and concealed accessory pathways with an acute outcome of “elimination of
anterograde conduction”
2. Outcome Proportion of AV nodal reentrant tachycardia procedures with an acute outcome of either Elimination of slow
pathway conduction or persistence of slow pathway conduction (with single echos but no inducible
tachycardia)
3. Outcome Proportion of atrial tachycardia procedures with acute procedural outcome of “substrate eliminated”
4. Outcome One year recurrence rate after acutely successful procedure for #1–4 above
5. Outcome Proportion of diagnostic and ablation electrophysiology procedures with a major intra or postprocedure
adverse event
6. Outcome Dose Area Product (cGy-cm2) during cardiac ablation procedure
7. Structure Participation in national database for pediatric electrophysiology diagnosis and treatment
8. Structure Intersocietal Accreditation Commission Accreditation of Electrophysiology Program
9. Structure Participation in a CIED (cardiac implantable electronic devices) registry, documenting indications, procedural
complications, approach, procedure success
10. Structure Presence of a dedicated electrophysiology/arrhythmia program, including (a) 24/7/365 pacemaker and ICD
interrogation and management, (b) comprehensive electrophysiology procedure laboratory including
dedicated EP staff and technological support, radiofrequency and cryoablation technology, and EP mapping
systems, (c) outpatient channelopathy and sudden cardiac arrest program.
11. Process Preprocedure conference with extended timeout
12. Process Use of a formal (written) protocol/checklist for post procedure handoff to ICU, ward, or recovery unit
13. Process Use of a radiation reduction protocol-strategy and radiation exposure tracking; establish absolute radiation
dose target for above (#1–4) tachycardia ablation substrates
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Care on these inpatient units, increasingly referred to as Acute Care
Units, aims to achieve excellent, efficient, and cost-effective surgical
and medical outcomes. As a result, there has been a recent sea change
of collective attention directed toward the unique elements of care in
these units.
The greatly improved pediatric cardiology mortality statistics have
cast a spotlight on other measures of clinical care associated with hos-
pitalization, such as complications, medium- and long-term morbidities,
and the cost and resources necessary to deliver desired outcomes.38
Critical care databases, namely the Virtual PICU System (VPS, LLC, Los
Angeles) and the Pediatric Cardiac Critical Care Consortium (PC4) clini-
cal registry as mentioned previously, aim to measure and understand
variation in practice and outcomes.
In 2015, the Pediatric Acute Care Cardiology Collaborative (PAC3)
emerged to improve care and outcomes in Acute Care Units. The aim
of PAC3 is to improve the safety and quality of pediatric inpatient car-
diac care with a focus on in-hospital short- and long-term outcomes
and the associated transition to outpatient care in a fashion that is
thoughtful, validated, transparent, sustained, and shareable. The
approach of PAC3 is intended to dovetail with the quality measures of
PC4 with an emphasis on outcome measures. The registry will be
appropriately risk-adjusted to account for case-mix patient factors.
Multiple cardiac centers across North America participate in PAC3.
The data dictionary for the PAC3 registry has been developed and data
will be collected starting in 2018. Ultimately, the goal is to develop
risk-adjustment models that can be used to transparently compare val-
uable outcome data across member centers (in an effort to provide an
enhanced continuum of newly acquired knowledge, data definitions
have been standardized with those of PC4 and STS whenever possible).
Comparison of data is intended to drive multicenter quality improve-
ment work similar in scope to what was achieved by the early extuba-
tion trial conducted by the Pediatric Heart Network.39 The first such
PAC3 effort is an ongoing multicenter quality improvement project
with the objective to collectively reduce postoperative chest tube dura-
tion, in an attempt to ultimately shorten hospital length of stay, lower
costs, and provide immediate patient benefit. Additionally, structure
and practice variation measures have already been collected across all
PAC3 member sites. Evidence to support an association between these
measures and the desired outcome measures will require time to deter-
mine. Suggested Inpatient unit metrics can be found in Table 8.
2.8 | Interventional cardiology
Clinical outcomes in the cardiac catheterization laboratory are central
to overall clinical outcomes in a congenital heart program. There have
been several clinical registries related to outcomes for cardiac catheter-
ization procedures over the last several decades. The Valvuloplasty and
Angioplasty of Congenital Anomalies (VACA) registry in the early
1990s was a voluntary registry of 27 institutions that published out-
comes on several different procedures and included some rudimentary
safety data.40,41
Food and Drug Administration (FDA) device trials for ASD, VSD,
and PDA devices gathered safety and efficacy data on device
performance.42 The MAGIC (Mid-Atlantic Group of Interventional Car-
diology) registry collected data on long-term outcomes on 8 interven-
tional procedures.43 Over 2400 procedures from 18 centers were
collected and analyzed. C3PO (Congenital Cardiac Catheterization Pro-
ject on Outcomes) started as an AHA funded project with 7 centers.
Data were collected on all catheterization procedures and served as
the basis for the Catheterization for Congenital Heart Disease Adjust-
ment for Risk Method (CHARM) method to allow for differences in
case mix between institutions and providers.44,45 CCISC (Congenital
Cardiovascular Interventional Study Consortium) is an international vol-
untary consortium of adult and pediatric providers with a focus on
complications and risk stratification as well as specific procedural
outcomes.46
The IMPACT Registry of the National Cardiovascular Data Registry
(NCDR) is a voluntary registry open to all centers and practices. Its
TABLE 8 Inpatient unit metrics
Metric Domain Definition
1. Outcome Postoperative inpatient acute care unit length of
stay (Risk-adjusted)
2. Outcome Rate of hospital discharge before noon
3. Outcome Rate of unplanned inpatient readmission within 7
and 30 days of hospital discharge (Risk-
adjusted)
4. Outcome Rate of unplanned ICU readmissions within 48
hours of transfer to the inpatient acute care
unit (Risk-adjusted)
5. Outcome Rate of unplanned ICU transfer at any time in the
hospitalization that leads to critical escalation
of care within one hour (intubation, initiation
of inotropes, ECMO) (Risk-adjusted)
6. Outcome Chest tube replacement (% chest tube replace-
ment within 48 hours after removal) (Risk-
adjusted)
7. Outcome Device-associated infection rates (CLABSI,
CAUTI)
8. Outcome Total cost of postsurgical care for STS benchmark
surgeries
10. Structure Participation in multi-institutional inpatient acute
care unit clinical registry and/or quality im-
provement collaborative
11. Structure Aggregate nursing education/experience and
staffing (hours per patient day)
12. Structure Utilization of a dedicated inpatient unit clinical
staff (physicians and midlevel providers)
13. Structure Postsurgical ambulation program (patients>3
years of age)
14. Process Program to communicate summary of hospitali-
zation with primary cardiologist at the time of
discharge
15. Process Unplanned event debriefing program (rapid
escalation of care for transfer to CICU or less
than 7-day hospital readmission)
16. Process Structured transfer handoff from ICU to inpatient
acute care unit.
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intent is to gather information on diagnostic and interventional cathe-
terization procedures on all pediatric patients and adult patients with
congenital heart disease to ultimately improve patient outcomes. As of
April 2016, IMPACT v.2 also collects safety and outcome data on pedi-
atric electrophysiology procedures and transcatheter pulmonary valve
replacement (TPVR). IMPACT v.2 is currently the only registry that is
audited, validated and adjudicated. Risk adjustment was also added to
IMPACT v.2 in 2016.47–50 Process and outcome measures refined in
these registries now help define quality in a pediatric cardiac catheteri-
zation program.51,52
Patient safety is critical in providing excellent clinical outcomes in
interventional cardiology. Monitoring and improving safety in the inter-
ventional lab is a marker of a quality program. Quality programs incor-
porate procedural communication and checklists as well as take steps
to reduce procedural related risks, such as radiation exposure. As with
other areas of congenital heart care, participation in programs that
track and share outcomes in an effort at collaborative learning is
encouraged. Suggested Interventional metrics can be found in Table 9.
2.9 | Noninvasive imaging
Noninvasive cardiac imaging is an integral component of the congenital
heart center, with accurate diagnostic imaging playing a key role in
patient outcomes in all clinical areas of the center. The link between
quality of imaging and patient outcome such as mortality or morbidity
is not usually direct; hence, many quality metrics in this area focus on
structure and process, with newer metrics focusing on other outcome
measures related to safety, accuracy and value.
Structurally, a comprehensive congenital heart center should pro-
vide, or have ready access to, the full range of noninvasive imaging
modalities: echocardiography (transthoracic, transesophageal, and
fetal); cardiac MRI, and cardiac CT. Many centers will also use addi-
tional imaging modalities such as intracardiac echo or intravascular
ultrasound. Imaging may be purely diagnostic, or may be integrated
with interventions, such as the use of echocardiographic guidance in
the operating or catheterization suites.
Process metrics in imaging focus on appropriateness of patient
selection as well as study performance, interpretation, and reporting.
Most of the available metrics focus on echocardiography given its
role as the initial and primary noninvasive cardiac imaging modality.
The Intersocietal Accreditation Commission (IAC) has established
standards for the structure and processes of adult and pediatric
echocardiography labs in North America. The standards are based
on published guidelines related to training, structure, and perform-
ance of an echocardiography lab.55–59 However, these standards are
considered a minimum and apply equally to small practices and large
tertiary heart centers. It is expected that comprehensive congenital
heart centers will meet metrics over and above the minimum stand-
ards for IAC accreditation.
To that end, a team established by the ACC’s ACPC section has
developed additional quality metrics specific to echocardiography, the
use of which should be standard in a state of the art congenital heart
center. Metrics currently available include: critical results reporting;
adverse events with sedated pediatric echocardiography; comprehen-
sive pediatric echocardiographic examination score; pediatric echocar-
diographic image quality score; pediatric echocardiographic diagnostic
accuracy in pediatric transthoracic echocardiography. Additional quality
metrics in development include: diagnostic accuracy in fetal echocardi-
ography; appropriateness of pediatric outpatient echocardiography;
adverse events with transesophageal echocardiography; comprehen-
sive CMR examination score; and adverse events with pediatric CMR.
These metrics begin to address the relationship between quality diag-
nostic imaging and patient outcomes.
Unlike subspecialties such as pediatric electrophysiology and inter-
ventional cardiology, to date there are no clinical data registries for pedi-
atric/congenital noninvasive imaging. The American Society of
Echocardiography (ASE) will be launching the first data registry for
echocardiography in 2017, initially with a basic set of echo measure-
ments, not unique to congenital heart disease including: LV size and
function, aortic valve gradient, pulmonary artery pressure, and pres-
ence/absence of pericardial effusion. Over time, the complexity of data
elements will be increased with the potential to add data elements
applicable to congenital heart disease and the ability to further associate
the quality of noninvasive imaging with patient outcome.60 For example,
the Pediatric Heart Network is currently carrying out a study “to estab-
lish a Z-score database for common echocardiographic measurements
based on a uniformly defined and racially diverse population of normal
children from multiple centers over a wide geographic area.”61 Sug-
gested Noninvasive imaging metrics can be found in Table 10.
In addition to these noninvasive imaging metrics that should be
considered currently, there are additional metrics that should be
TABLE 9 Interventional metrics
Metric Domain Definition
1. Outcome Clinical outcomes as detailed in the ACC IMPACT
registry53
2. Outcome Proportion of diagnostic and interventional pro-
cedures with a major intra or postprocedure
adverse event.
3. Outcome Proportion of patients who receive radiation
dose greater than 95th percentile of bench-
mark data (procedure specific).54
4. Structure Participation in a national database for pediatric
and congenital heart disease cardiac catheter-
ization and intervention.
5. Structure Participation in local quality improvement efforts
or national pediatric quality improvement net-
work (eg, radiation reduction) within focus on
improving process or outcomes in the cardiac
catheterization laboratory.
6. Structure Standardized adverse event (O/E) ratio reporting
7. Process Precatheterization conference or extended time
out for all patients undergoing a catheteriza-
tion procedure
8. Process Use of a formal and documented protocol/
checklist for postcatheterization to ICU, ward
or recovery room.
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discussed as potential next steps in measurement. These include: (1)
comprehensive fetal echo metric, (2) fetal echo diagnostic accuracy
metric, (3) TEE adverse events metric, (4) comprehensive CMR study
metric, and (5) CMR adverse events metric.
2.10 | Nursing
Nurses have a significant role in inpatient and outpatient clinical prac-
tice. It is critical to measure their contribution to the provision of safe,
effective, efficient, equitable, timely, and patient/family centered
care.62–65 Over the last decade, evidence linking the impact of pediatric
nursing care on pediatric cardiovascular patient outcomes has sup-
ported the identification and development of nurse-sensitive quality
measurement.66–72 The translation from evidence to implementation of
pediatric cardiovascular nursing measurement for national benchmark-
ing was the result of a charge received in 2008 from the American Col-
lege of Cardiology (ACC) Pediatric Quality Metric Working Group
(QMWG). To develop a nursing sensitive metric, the nursing project
leader engaged expert clinicians, administrators and nurse scientists
from 15 different institutions. Through consensus, the importance of
nutrition for children with cardiac disease was highlighted and further
identified as a critical component of pediatric cardiac nursing care that
contributed to overall patient outcomes. Additionally, documentation
of daily fluid intake was identified as a standardized activity performed
by nurses, but there was no consistent documentation of assessment
or measurement of nutritional intake of infants during hospitalization.
In its final form “Documentation of Nutrition” is a metric of daily
recording of feeding status and calorie intake for all infants one month
or older admitted for surgical intervention or medical intervention/
management for more than one 24-hour period. Following an internal
and external review and endorsement of the measure, 15 pediatric car-
diovascular programs implemented the measure and successfully
improved the practice of daily documentation of nutrition. The ACC
QMWG nursing experience demonstrated a number of successes: (1)
development of a collaborative, consensus-based approach among
pediatric cardiac nurse scientists, administrators, and clinical experts to
identify and develop a quality nursing measurement; (2) feasibility of
implementing a measure and data collection strategy in 15 institutions
across the country; and (3) a commitment in identification and testing
of other measures in a consensus based manner.
This effort provided the impetus for the inception of the Consor-
tium for Congenital Cardiac Care Measurement of Nursing Practice
(C4-MNP).62 Donabedian’s framework of structure, process and out-
comes along with the Institute of Medicine’s quality domains are used
to guide a national community of researchers, administrators and
expert clinicians committed to rigorous measurement of the quality of
care required by nurses who participate in achieving optimal outcomes
for children with cardiac disease.8,62,73 Today the C4-MNP has
expanded the scope of nurse sensitive quality measurement to inform
optimal staffing models, work environments and evidence based prac-
tice with collaboration of 32 pediatric cardiovascular programs in the
United States.8,62,73
In 2015 the ACC published a health policy statement on cardiovas-
cular team-based care and the role of advanced practice providers.74
This manuscript emphasized the role of nurses and advanced practice
providers, as well as other clinical support staff (eg, pharmacy, dis-
charge coordinators, nutritionists) to enhance efficiency and patient
clinical outcomes. With every team member functioning at top of
license, patient outcomes such as medication compliance and decrease
in unplanned readmissions can be measured. Importantly, these teams
help to coordinate patient care between the inpatient and outpatient
arenas. Suggested Nursing metrics can be found in Table 11.
3 | DISCUSSION
This manuscript provides guidance to programs responsible for the
care of patients with congenital heart disease. Building on the 2002
American Academy of Pediatrics published “Guidelines for Pediatric Car-
diovascular Centers,” this work applied the Donebedian model to iden-
tify important outcome, structure and process metrics currently used
TABLE 10 Noninvasive imaging metrics
Metric Domain Definition
1. Outcome Adverse events with sedated pediatric echocar-
diography metric
2. Outcome Pediatric TTE diagnostic accuracy metric
3. Structure Participation in ACPC Quality Network
4. Structure Comprehensive Noninvasive cardiac imaging
program: Transthoracic Echo; Transesophageal
Echo; Fetal Echo; Cardiac MRI; Cardiac CT;
Stress echo
5. Structure Intersocietal Accreditation Commission Accred-
itation of Echocardiography Program
6. Process Pediatric TTE image quality metric
7. Process Comprehensive pediatric TTE metric
8. Process Critical results reporting in pediatric echocardio-
graphy metric
TABLE 11 Nursing metrics
Metric Domain Definition
1. Structure Overall Years of Nursing Experience: Unit-level
measure of the percentage of registered
nursing staff providing patient care that has 0–
2 years of any clinical experience
2. Structure Bachelor of Science in Nursing (BSN) Education:
Unit-level measure of the percentage of
registered nursing staff who are at least BSN-
prepared
3. Structure Nursing Certification: Unit-level measure of the
percentage of registered nursing staff provid-
ing patient care who are CCRN or CPN
certified
4. Process Documentation of Nutrition: Monthly measure
of daily documentation of feeding status and
received calories/kg/day for infants </5 30
days of age admitted for surgical or medical
intervention for>24-hour period
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or proposed by groups of clinicians, administrators, and patients/fami-
lies.1 The intent of this work is to provide standardization around how
congenital heart centers might measure their program characteristics in
areas that are felt to be related to high value, safe clinical care resulting
in excellent clinical outcomes.
This approach to defining metrics was unique given that we took a
broad collaborative approach to define potentially important measures.
While we used the Donabedian framework of focus on process, struc-
ture and outcome metrics, we emphasize that patient outcomes and
the value they provide to patients should be central to what programs
measure and report. Our methodology allowed clinicians, administra-
tors, and parents to collectively decide what matters most. While these
metrics may not be perfect, they will allow us to understand some of
the variability that may exist among centers caring for patients with
congenital heart disease. It has been shown in a broad range of indus-
tries, including healthcare that reduction in process variation typically
results in better overall outcomes.75,76 This concept has been demon-
strated by a number of groups within the field of congenital heart dis-
ease.77,78 Once we understand the variation that exists among care
center structure and processes we can collaboratively work to reduce
that variability and expect to see improved overall outcomes.
Measuring a standard set of outcome, structure and process met-
rics at a program level is especially important for our families. As noted
by those involved in the data transparency movement, patients and
families are clamoring for comparable information from programs as
they decide where to seek care for themselves or their loved ones.4 As
clinicians, we have the responsibility to provide accurate and impactful
data to our patients to help them make informed decisions about their
care. In nearly every domain of metric development (Table 1) there is
need for more and better measures of short- and long-term outcomes.
Because outcomes are the heart of what these centers strive for, and
what patients demand, it is critical for clinicians and programs to close
this outcome metric gap in the near future.
While we believe that the metrics listed in this report are impor-
tant to track at centers caring for patients with congenital heart dis-
ease, we make these recommendations fully aware of the environment
of “over measurement” in which we currently operate clinically. We are
in a period where healthcare has been flooded with measurement,
often mandated by regulatory bodies and at times self-imposed. A
recent NIH workgroup has addressed the issue of exponentially
increasing data and the need for collaborative agreement regarding key
quality metrics and the concept of big data.73 As noted by Berwick,
“intemperate measurement is as unwise and irresponsible as is intem-
perate healthcare.”79 Specific to our field, Redington recently noted
similar frustrations with collecting massive amounts of information into
clinical registries, and the cost associated with this work.80 Part of the
angst around the abundance of metrics in healthcare is the cost of col-
lecting the data required to report many metrics.81 As we propose
additional metrics for our field, we agree with the sentiment that we
need to focus on “measuring what matters” and doing so in the most
efficient and affordable way possible. The current effort, initiated at
the 2016 Congenital Heart Community Day, provides an opportunity
for clinicians, patients and administrators to collaboratively define
“what matters.” Going forward, it will be wise for these metrics to be
matched to ongoing or existing work, rather than to invent new meth-
ods to measure and track these metrics. Some examples of potential
systems that might be used to track program level metrics include the
American College of Cardiology Adult Congenital and Pediatric Quality
Network (QNet) or using this group of metrics to influence the metrics
chosen for measurement by the US News and World Report.20
4 | CONCLUSION
Dynamic forces such as the change in healthcare reimbursement,
increasing demand for transparency of outcomes, and evolving diag-
nostic and treatment technology and procedures provide the rationale
for collaboration amongst pediatric cardiology centers today. This col-
laborative effort has helped to define the most critical quality metrics
which can lead to development of established center-level national
benchmarks. The elimination of unnecessary variability is an important
local concept, ensuring consistent care amongst providers, but also can
be applied to the national effort between and among centers. Engage-
ment of patients and families to define meaningful structure, process,
and outcome metrics will ensure the greatest return on the investment
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